Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Ratiopharm patents

Patents where

Current Assignee

Name

Ratiopharm

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7732474 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation	Patent 7732474 was granted and assigned to Ratiopharm on June, 2010 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	7732474	June 8, 2010
‌ US Patent 7105180 Stable galenic preparations comprising a benzimidazole and method for the production thereof	Patent 7105180 was granted and assigned to Ratiopharm on September, 2006 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	7105180	September 12, 2006
‌ US Patent 7932403 Process for preparing pyrrole derivatives and intermediates	Patent 7932403 was granted and assigned to Ratiopharm on April, 2011 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	7932403	April 26, 2011
‌ US Patent 9796659 Derivatives of polyhydroxy compounds	Patent 9796659 was granted and assigned to Ratiopharm on October, 2017 by the United States Patent and Trademark Office.	Ratiopharm	Ratiopharm	United States Patent and Trademark Office	9796659	October 24, 2017
‌ US Patent 9663480 BIS-MMF derivatives	Patent 9663480 was granted and assigned to Ratiopharm on May, 2017 by the United States Patent and Trademark Office.	Ratiopharm	Ratiopharm	United States Patent and Trademark Office	9663480	May 30, 2017
‌ US Patent 9969674 MMF-derivatives of ethyleneglycols	Patent 9969674 was granted and assigned to Ratiopharm on May, 2018 by the United States Patent and Trademark Office.	Ratiopharm	Ratiopharm	United States Patent and Trademark Office	9969674	May 15, 2018
‌ US Patent 9012464 Salts and polymorphic forms of Afatinib	Patent 9012464 was granted and assigned to Ratiopharm on April, 2015 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	9012464	April 21, 2015
‌ US Patent 7786156 Synthesis methods and intermediates for the manufacture of Rizatriptan	Patent 7786156 was granted and assigned to Ratiopharm on August, 2010 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	7786156	August 31, 2010
‌ US Patent 9480655 Solid pharmaceutical dosage form of dolutegravir	Patent 9480655 was granted and assigned to Ratiopharm on November, 2016 by the United States Patent and Trademark Office.	Ratiopharm	Ratiopharm	United States Patent and Trademark Office	9480655	November 1, 2016
‌ US Patent 10377758 Co-crystals of ibrutinib with carboxylic acids	Patent 10377758 was granted and assigned to Ratiopharm on August, 2019 by the United States Patent and Trademark Office.	Ratiopharm	Ratiopharm	United States Patent and Trademark Office	10377758	August 13, 2019
‌ US Patent 9339550 Solid ivabradine-containing composition	Patent 9339550 was granted and assigned to Ratiopharm on May, 2016 by the United States Patent and Trademark Office.	Ratiopharm	Ratiopharm	United States Patent and Trademark Office	9339550	May 17, 2016
‌ US Patent 7799952 Stereoselective method for the production of (R)-Dimepranol	Patent 7799952 was granted and assigned to Ratiopharm on September, 2010 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	7799952	September 21, 2010
‌ US Patent 9468685 Methods of preparing a liquid formulation of G-CSF	Patent 9468685 was granted and assigned to Ratiopharm on October, 2016 by the United States Patent and Trademark Office.	Ratiopharm	Ratiopharm	United States Patent and Trademark Office	9468685	October 18, 2016
‌ US Patent 9238007 Method for the production of a medicament containing tadalafil	Patent 9238007 was granted and assigned to Ratiopharm on January, 2016 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	9238007	January 19, 2016
‌ US Patent 8148550 Method for the production of statins	Patent 8148550 was granted and assigned to Ratiopharm on April, 2012 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	8148550	April 3, 2012
‌ US Patent 10526326 Crystalline form and acetic acid adducts of palbociclib	Patent 10526326 was granted and assigned to Ratiopharm on January, 2020 by the United States Patent and Trademark Office.	Ratiopharm	Ratiopharm	United States Patent and Trademark Office	10526326	January 7, 2020
‌ US Patent 8992976 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and methods for producing the same	Patent 8992976 was granted and assigned to Ratiopharm on March, 2015 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	8992976	March 31, 2015
‌ US Patent 9315450 Desfesoterodine salts	Patent 9315450 was granted and assigned to Ratiopharm on April, 2016 by the United States Patent and Trademark Office.	Ratiopharm	Ratiopharm	United States Patent and Trademark Office	9315450	April 19, 2016
‌ US Patent 8946482 Salts of rasagiline and pharmaceutical preparations thereof	Patent 8946482 was granted and assigned to Ratiopharm on February, 2015 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	8946482	February 3, 2015
‌ US Patent 9480755 Pharmaceutical composition comprising dapagliflozin and cyclodextrin	Patent 9480755 was granted and assigned to Ratiopharm on November, 2016 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	9480755	November 1, 2016
‌ US Patent 8663661 Solid pharmaceutical dosage form of ticagrelor	Patent 8663661 was granted and assigned to Ratiopharm on March, 2014 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	8663661	March 4, 2014
‌ US Patent 8703203 Oral dosage form of deferasirox	Patent 8703203 was granted and assigned to Ratiopharm on April, 2014 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	8703203	April 22, 2014
‌ US Patent 10059715 Acid addition salt of ibrutinib	Patent 10059715 was granted and assigned to Ratiopharm on August, 2018 by the United States Patent and Trademark Office.	Ratiopharm	Ratiopharm	United States Patent and Trademark Office	10059715	August 28, 2018
‌ US Patent 10464903 Process for preparing quinolin-2-yl-phenylamine derivatives and their salts	Patent 10464903 was granted and assigned to Ratiopharm on November, 2019 by the United States Patent and Trademark Office.	Ratiopharm	Ratiopharm	United States Patent and Trademark Office	10464903	November 5, 2019
‌ US Patent 8252336 Escitalopram and solid pharmaceutical composition comprising the same	Patent 8252336 was granted and assigned to Ratiopharm on August, 2012 by the United States Patent and Trademark Office.		Ratiopharm	United States Patent and Trademark Office	8252336	August 28, 2012

Results per page:

51 results

0 selected

51 results

0 selected